Does dapsone cause a rebound effect after stopping it

Last updated 2026-07-30

Is there a real dapsone rebound effect after you stop using it?

No published trial has documented a rebound flare from stopping topical dapsone gel that's worse than the acne you started with. The two 12-week trials that got Aczone 5% approved by the FDA in 2005, and the later trials supporting Aczone 7.5% in 2016, tracked patients on active drug versus vehicle gel. They measured improvement during treatment. Neither program was designed to follow patients after discontinuation looking for a flare-up, so there's no dataset that directly answers "what happens six weeks after you stop." ^{[1] [2]} What's well documented is that acne is a chronic condition. It keeps producing sebum, keratin plugs, and Cutibacterium acnes activity regardless of what topical you were using. When you stop any effective acne treatment, whether it's dapsone, a retinoid, or benzoyl peroxide, the underlying disease process is still there. Skin usually drifts back toward its untreated baseline over four to eight weeks, sometimes faster if you also stop moisturizing or sun protection habits you'd built around the routine. That drift feels like "rebound" to a lot of people. It's really just the absence of a drug that was suppressing inflammation. This is different from true rebound phenomena seen with some other dermatology drugs, like the flare some patients get after stopping long-term topical steroids (a recognized entity sometimes called topical steroid withdrawal). Dapsone gel isn't a steroid and doesn't work by the same mechanism, and nothing in the FDA labeling or the trial literature describes a steroid-withdrawal-style rebound for it. ^[3]

Why does acne seem to come back worse after stopping dapsone gel?

A few things get blamed on "rebound" that are really just timing and expectation problems. First, dapsone gel takes real time to build its effect. Trial data on Aczone 7.5% showed meaningful separation from vehicle by week 2, with continued improvement through week 12, meaning you were seeing a slow accumulation of benefit, not an instant fix. ^[2] Stopping abruptly means you lose that accumulated benefit on a similar slow curve, and by week 4 to 8 post-stop, a lot of that suppression has worn off. It can feel abrupt to you even though the biology is gradual. Second, people often stop dapsone and several other things at once. New moisturizer routine, change in birth control, stress season, a switch away from a cleanser they'd been pairing with it. Any of those can independently trigger a flare, and it's easy to pin the blame on the one product you remember stopping. Third, there's a selection bias in who researches "rebound effect" online. People whose acne stayed clear after stopping rarely go looking for information, so the visible complaints skew toward the flare-up crowd. That doesn't mean rebound isn't happening to some individuals, just that there's no controlled evidence proving it's a drug-specific phenomenon rather than acne's normal relapse pattern. If you want to see what realistic improvement and plateau timelines look like before you make decisions about stopping, the dapsone results timeline breaks down the week-by-week trial data.

Does dapsone gel need to be used continuously to keep acne away?

Mostly yes. Topical dapsone is a maintenance-style treatment, not a cure, and dermatology guidance treats acne overall as a chronic disease that needs ongoing management rather than a fixed course. The American Academy of Dermatology's acne management guideline describes long-term topical therapy as standard for maintaining control, and doesn't describe a defined stop-point where acne is expected to be permanently resolved. ^[4] In practice, that means most people either keep using it (often tapering frequency to two or three times a week once skin is clear) or transition to a different maintenance topical, like a retinoid, once they've responded. Stopping cold with no replacement plan is the scenario most likely to look like a "rebound," because you've gone from active suppression to nothing. If you're trying to figure out how much improvement to expect before you consider stopping or tapering, dapsone before and after photos and patient-reported outcomes give a more concrete picture than percentages alone.

What do the actual dapsone acne trials show about relapse after stopping?

The core efficacy numbers come from two identically designed 12-week, randomized, double-blind, vehicle-controlled trials of Aczone 5% gel in about 3,000 patients combined, published in the Journal of Drugs in Dermatology. At week 12, roughly 41-42% of patients using dapsone gel achieved "success" (defined as a global score of clear or almost clear plus a set reduction in lesion counts) versus about 30-33% on vehicle gel. ^[1] The Aczone 7.5% program (referenced in the FDA label) showed comparable separation from vehicle over the same 12-week window with less frequent dosing. ^[2] Neither trial had a post-discontinuation follow-up arm publicly reported that measured relapse or rebound severity. That's a real gap in the literature. Anyone telling you there's a specific percentage of patients who "rebound" after stopping dapsone is not citing an actual study, because that study doesn't exist in the public record. | What's measured | Data available | What's NOT measured |

Is oral dapsone rebound the same thing as topical dapsone rebound?

No, and mixing these up is the most common mistake people make researching this topic. Oral dapsone is a sulfone antibiotic, taken systemically, used for conditions like dermatitis herpetiformis, leprosy, and some autoimmune blistering diseases. It's a completely different risk profile from the 5% or 7.5% gel sold as Aczone for acne. ^[5] Oral dapsone carries a boxed warning for hemolytic anemia, which is dose-dependent and worsens with continued use, not something that flares up after you stop. Its FDA label states dapsone "can cause hemolysis, especially in individuals with glucose-6-phosphate dehydrogenase (G6PD) deficiency," and recommends G6PD screening before starting therapy. ^[5] Methemoglobinemia and, rarely, dapsone hypersensitivity syndrome (a severe, sometimes fatal reaction involving fever, rash, and organ involvement, generally appearing two to six weeks after starting the drug) are additional risks tied to being on the drug, not to stopping it. ^{[5] [6]} There's no clinical concept of "rebound" for oral dapsone in the way people mean it for acne gel. If anything, the concerning direction with oral dapsone is the opposite: risks accumulate the longer you stay on it, and abrupt discontinuation is sometimes exactly what a physician orders if hemolysis or hypersensitivity symptoms show up.

Why does oral dapsone require G6PD testing before you start?

Because G6PD deficiency, an inherited enzyme deficiency affecting roughly 400 million people worldwide and about 1 in 10 African American males in the US, leaves red blood cells unable to handle the oxidative stress that dapsone's metabolites cause. Without that enzyme working properly, oral dapsone can trigger acute hemolytic anemia, sometimes severe enough to require transfusion or hospitalization. The FDA label is direct about this: dapsone tablets should be used "with caution" in G6PD-deficient patients, with monitoring of hemoglobin and reticulocyte counts, and screening before starting therapy is the standard of care recommended by dermatology and infectious disease references. ^[5] This is a pre-treatment safety step, not something related to a rebound after stopping. Topical dapsone gel does not carry this same requirement for most patients. Systemic absorption through skin is low, and the Aczone label notes that clinically relevant hemolysis has not been observed in G6PD-deficient patients using the topical gel in the studies reviewed for approval. ^[1] That's the single most important distinction to keep straight: G6PD testing is an oral-dapsone issue first, and a much smaller topical-dapsone footnote second, not the reverse.

What are the actual symptoms of a dapsone hypersensitivity reaction, and is it a form of rebound?

Dapsone hypersensitivity syndrome isn't rebound at all. It's a drug reaction that happens while you're on oral dapsone, typically two to six weeks after starting. Symptoms include fever, a widespread rash, swollen lymph nodes, and involvement of internal organs, most often the liver. Case series in the dermatology literature describe mortality estimates historically cited around 9-11% for this syndrome when it's severe and not caught early. ^[6] This reaction is a reason oral dapsone requires medical supervision and follow-up bloodwork, not a reason to fear stopping topical acne gel. If you develop fever, rash, or unusual fatigue while on any dapsone product, oral or topical, that's a call-your-prescriber-immediately situation, not a wait-and-see one. None of this applies to the experience of finishing a tube of Aczone and noticing a few new pimples a month later. That's acne being acne, not a hypersensitivity reaction and not systemic drug withdrawal.

Should you taper off dapsone gel instead of stopping abruptly?

There's no pharmacological requirement to taper topical dapsone the way you might taper a topical steroid or an oral medication with withdrawal potential. Dapsone gel doesn't have documented withdrawal pharmacology. That said, a practical taper (stepping from daily use down to every other day, then twice weekly) is a reasonable way to judge whether your skin still needs it, and it avoids the psychological "cliff edge" of stopping cold and blaming the drug for what's really acne's normal return. Most dermatology guidance frames this as ongoing maintenance dosing rather than a formal taper protocol, similar to how retinoids are often continued at reduced frequency for years rather than stopped outright. ^[4] If your skin stays clear for two to three months at reduced frequency, that's a reasonable signal you might not need daily dosing anymore. If it doesn't, that's information too, not proof of rebound, just proof you still have active acne. For a side-by-side on when tapering versus switching to another topical makes more sense, dapsone pros and cons covers the tradeoffs in more depth.

Is topical dapsone (Aczone) worth using if the results might not last after stopping?

For a lot of people with mild to moderate inflammatory acne, yes, particularly if other topicals irritated their skin. Aczone's appeal is a relatively low irritation profile compared to benzoyl peroxide or retinoids, which matters most for people who couldn't tolerate those first-line options. ^[1] But "worth it" needs to be judged against what dapsone gel actually is: an ongoing management tool, not a fix you use for 12 weeks and then walk away from acne-free forever. If your expectation going in is a permanent cure, you're going to experience the natural return of acne after stopping as a letdown, maybe even a "rebound," when it's really just an expectation mismatch. If your expectation is "this controls my breakouts while I use it, and I'll need a plan for after," you'll have a much more accurate read on your own results. A deeper breakdown of who tends to benefit most, and who's more likely to be disappointed, is in is dapsone worth it. Real patient experiences, including people who quit and restarted, are collected in dapsone reviews.

How should you decide whether to keep using dapsone gel long-term?

This is a conversation for a prescriber, not a forum thread, but a few practical markers help. If you've been clear for two to three months and want to test tapering, do it gradually rather than stopping outright, and watch over six to eight weeks rather than judging after two weeks. If acne returns to roughly what it was before treatment, that's relapse, not rebound, and it tells you your skin still needs active management, whether that's dapsone again or something else. Provider-reviewed telehealth routes exist specifically so a clinician sees your skin history and any relevant labs before refilling or adjusting a prescription, rather than you guessing at dosing changes alone. Dapsone Rx works with a provider-reviewed process and names Belmar Pharmacy as the fulfilling pharmacy partner for prescriptions written through that route, which matters if you want a documented, monitored path rather than sourcing a topical acne treatment informally. If oral dapsone is being considered for a different, non-acne skin condition, that decision should include G6PD screening and a clinician who can monitor bloodwork over time, given the hemolysis and hypersensitivity risks described above. ^{[5] [6]} That's a different conversation entirely from whether to keep using a tube of acne gel.

Frequently asked questions

Does acne come back after you stop using dapsone gel?

Often, yes, but that's because dapsone controls acne rather than curing it, not because of a drug-specific rebound. Once you stop, the underlying causes of acne (oil production, clogged pores, bacteria) are still present, so breakouts tend to drift back toward baseline over four to eight weeks, similar to stopping any other topical acne treatment.

Is there a withdrawal effect from stopping dapsone gel?

No documented withdrawal syndrome exists for topical dapsone in the FDA trial data or product labeling. Unlike topical steroids, which can cause a recognized withdrawal flare, dapsone gel's mechanism doesn't carry that risk profile in published research. What looks like withdrawal is usually acne's natural relapse pattern.

How long does it take for dapsone gel to work, and does that affect rebound?

Trial data on Aczone 7.5% shows measurable improvement over vehicle gel by around week 2, with continued gains through week 12. ^[2] Because the benefit builds slowly, the loss of benefit after stopping also unfolds gradually, over weeks, which is part of why the change can feel like a sudden rebound when it's really a gradual fade.

Can I use dapsone gel only when I have a breakout, then stop?

That's not how the trial evidence supports using it. Studies measured consistent daily or twice-daily use over 12 weeks, not as-needed spot treatment. ^[1][2] Using it inconsistently likely means you're not getting the accumulated benefit shown in trials, and your "rebound" would really just be undertreated acne.

Is oral dapsone rebound dangerous?

Oral dapsone doesn't have a documented rebound-on-stopping phenomenon. Its serious risks (hemolytic anemia, methemoglobinemia, dapsone hypersensitivity syndrome, agranulocytosis) occur while a person is taking the drug, tied to dose and duration, and sometimes worsen the longer it's continued rather than after it's stopped. ^[6][7]

Why does oral dapsone require a G6PD test but topical Aczone usually doesn't?

Oral dapsone is absorbed systemically and its metabolites cause oxidative stress that G6PD-deficient red blood cells can't handle, risking hemolytic anemia. ^[6][8] Topical Aczone gel has low systemic absorption, and studies reviewed for FDA approval didn't show clinically relevant hemolysis in G6PD-deficient users of the topical form. ^[1]

What percentage of people respond to topical dapsone for acne?

Across the Aczone 5% trials, about 41-42% of patients reached treatment success (clear or almost clear skin plus reduced lesion counts) at week 12, versus roughly 30-33% on vehicle gel. ^[1] No published data reports what percentage relapse or "rebound" after stopping.

Can you taper off dapsone gel instead of stopping suddenly?

Yes, and it's a reasonable practical approach even without a documented pharmacological need to taper. Stepping down from daily to every-other-day to twice weekly over a few months lets you see whether your skin still needs the medication, without the abrupt all-or-nothing stop that makes normal relapse feel like rebound.

What is dapsone hypersensitivity syndrome and is it related to rebound?

It's a serious reaction to oral dapsone, usually appearing two to six weeks after starting, involving fever, rash, swollen lymph nodes, and organ involvement (often the liver). Severe untreated cases have historically carried mortality estimates around 9-11%. ^[7] It's unrelated to stopping the drug and unrelated to topical acne gel.

Does stopping dapsone gel cause worse acne than before you started?

There's no trial evidence that stopping dapsone gel causes acne worse than your pre-treatment baseline. What people describe as "worse than before" is more likely a combination of normal relapse, other routine changes made at the same time, and the psychological contrast with how clear skin looked while on treatment.

Is topical dapsone safe to use indefinitely?

Long-term topical use is common in dermatology practice and is how the drug is generally positioned in treatment guidelines, similar to long-term retinoid use. ^[4] There's no defined maximum duration in the Aczone label, but ongoing use should still be reviewed periodically with a prescriber, and a provider-reviewed route is the safest way to manage refills over time.

Should I get tested for G6PD deficiency before starting dapsone?

If you're being prescribed oral dapsone, yes, this is standard practice and specifically recommended in the FDA label given hemolysis risk in G6PD-deficient patients. ^[6] If you're using topical Aczone for acne, G6PD testing isn't typically required, since the studies behind its approval didn't show the same hemolysis signal at the low systemic absorption levels of the gel. ^[1]

Sources

1. FDA, Aczone (dapsone) Gel 5% Prescribing Information: 12-week trial success rates (~41-42% vs ~30-33% vehicle) and G6PD/hemolysis data for topical dapsone 5% gel
2. FDA, Aczone (dapsone) Gel 7.5% Prescribing Information: Aczone 7.5% once-daily trial design and timeline of efficacy separation from vehicle
3. American Academy of Dermatology, Guidelines of care for the management of acne vulgaris: Acne is managed as a chronic condition requiring ongoing/maintenance therapy rather than a fixed cure timeline
4. FDA, Dapsone Tablets USP Prescribing Information: Oral dapsone label data on hemoglobin and reticulocyte monitoring related to hemolysis risk
5. StatPearls (NCBI Bookshelf), Dapsone Toxicity: Dapsone hypersensitivity syndrome timing (2-6 weeks after starting), symptoms, and historical mortality estimates
6. CDC, Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency: G6PD deficiency prevalence figures and population risk groups